Table 3.
Clinical findings comparing Covid-19 year with the two preceding years regarding abscess localization, presence of desolate dental status, length of hospitalization and ICU stay, and time to treatment
| Clinical findings |
Preceding years n = 663 (%) |
Covid-19 year n = 298 (%) |
| Abscess type and location | ||
| Pericoronitis-abscess | 5 (0.8) | 1 (0.3) |
| Apical periodontitis/ Periimplantitis-abscess | 23 (3.5) | 14 (4.7) |
| Enosseal abscess | 1 (0.1) | 0 (0) |
| Subperiosteal abscess | 18 (2.7) | 17 (5.7) |
| Submucosal abscess | 52 (7.8) | 16 (5.4) |
| Fossa canaina abscess | 130 (19.6) | 64 (21.5) |
| Parotid abscess | 1 (0.1) | 0 (0) |
| Lip abscess | 4 (0.6) | 0 (0) |
| Tongue abscess | 2 (0.3) | 0 (0) |
| Palatinal abscess | 5 (0.8) | 5 (1.7) |
| Buccal abscess | 45 (6.8) | 19 (6.4) |
| Retromaxillary abscess | 0 (0) | 2 (0.7) |
| Chin abscess | 5 (0.8) | 0 (0) |
| Paramandibular abscess | 170 (25.6) | 57 (19.1) |
| Perimandibular abscess | 91 (13.7) | 61 (20.5) |
| Sublingual abscess | 26 (3.9) | 9 (3.0) |
| Submental abscess | 13 (2.0) | 6 (2.0) |
| Submandibular abscess | 35 (5.3) | 8 (2.7) |
| Masseterico-/pterygomandibular abscess | 15 (2.3) | 6 (2.0) |
| Para-/retropharyngeal abscess | 3 (0.5) | 1 (0.3) |
| Several lodges abscess | 1 (0.1) | 3 (1.0) |
| Not other specified abscess | 18 (2.7) | 9 (3.0) |
| Desolate dental chart | 171 (25.8) | 109 (36.6) |
| Hospitalisation (days) | mean 6 (1–51) | mean 6 (1–50) |
| Length of ICU stay (days) | mean 10 (1–27) | mean 5 (1–12) |
| Time to treatment (days) | mean 7 (1–270) | mean 8 (1–320) |
|
Potentially life-threatening cases (ICU patients) n = 25 |
Preceding years n = 17 (68) |
Covid-19 year n = 8 (32) |
| Massive pharyngeal swelling (potentially life-threatening) | 11 (44) | 7 (28) |
| Dysphagia | 1 (4) | 0 (0) |
| Oxygen saturation drop | 2 (8) | 0 (0) |
| Acute kidney disease | 0 (0) | 1 (4) |
| Mediastinitis | 1 (4) | 0 (0) |
| Sepsis | 2 (8) | 0 (0) |